Image source: The Motley Fool.
Intercept Pharmaceuticals, inc (NASDAQ: ICPT)
Q3 2021 Earnings Call
Nov 3, 2021 , 8:30 a.m. ET
Operator
For further details see:
Intercept Pharmaceuticals, inc (ICPT) Q3 2021 Earnings Call TranscriptImage source: The Motley Fool.
Intercept Pharmaceuticals, inc (NASDAQ: ICPT)
Q3 2021 Earnings Call
Nov 3, 2021 , 8:30 a.m. ET
Operator
For further details see:
Intercept Pharmaceuticals, inc (ICPT) Q3 2021 Earnings Call TranscriptMarket Wire News is a media platform, the information on this page was provided by Motley Fool via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Intercept Pharmaceuticals Inc. Company Name:
ICPT Stock Symbol:
Market:
Intercept Pharmaceuticals Inc. Website:
sNDA intended to satisfy post-marketing requirements to confirm a clinical benefit in patients with PBC Precedent-setting submission includes data from post-marketing studies COBALT and Study 401 as well as real-world evidence from a claims database and patient registries FDA has assign...
Monday, Gilead Sciences Inc (NASDAQ:GILD) agreed to acquire CymaBay Therapeutics Inc (NASDAQ:CBAY) for $32.50 per share i...
Data from two Phase 2 studies in PBC show combination of OCA + bezafibrate achieved biochemical remission (normalization of ALP, total bilirubin, GGT, ALT and AST) in 40-44% of patients in the first 12 weeks OCA 5 or 5-10 mg + bezafibrate 400 mg cohorts in both studies showed a >60% ...